Clinical trial
Effects of Lisdexamfetamine on Bradyphrenia in Multiple Sclerosis
NCT01615887 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Lisdexamfetamine on Bradyphrenia in Multiple Sclerosis
- Lead sponsor
- State University of New York at Buffalo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- August 31, 2011
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.